Here are two high quality ASX 200 shares rated as buys…
The post Broker names 2 of the best ASX 200 shares to buy now appeared first on The Motley Fool Australia. –
Investors that are looking for some new shares to buy might want to look at the two listed below.
These two ASX 200 shares have been tipped to climb meaningfully higher from where they trade today. Hereâs what you need to know about them:
CSL LimitedÂ (ASX: CSL)
The first ASX 200 share that analysts are saying investors should buy is biotherapeutics giant, CSL.
Over the last century, the company has developed a range of lifesaving and lucrative plasma therapies and vaccines.Â It continues this work today with its huge annual investment in R&D and is also in the process of acquiring Vifor Pharma, which is focused on iron deficiency, nephrology and cardio-renal therapies.
Citi is positive on CSL and sees plenty of upside ahead for its shares. Particularly given its belief that CSL will deliver above consensus earnings in the coming years. The broker has a buy rating and $335.00 price target. Citi said:
We expect the market to shift its focus to the strong underlying plasma product demand, and the closure the Vifor deal, both of which should lead to strength in the share price.
Our FY23-24 EPS estimates remain 5-6% above consensus (we have included the Vifor consensus estimates in our forecasts). The next catalyst will be the closure of the Vifor transaction which is now expected to complete by the end of Sept (previously June). Maintain Buy, A$335 TP.
Goodman GroupÂ (ASX: GMG)
Another ASX 200 share that is highly rated is Goodman. It is a global integrated commercial and industrial property company with a world class property portfolio.
Goodman’s high quality properties have exposure to key growth markets such as ecommerce and are in demand with tenants. The company also has a development pipeline which looks set to support further solid earnings growth in the coming years.
Citi is also positive on Goodman’s future. Its analysts currently have a buy rating and $29.50 price target on its shares. The broker expects Goodman to outperform its upgraded earnings guidance in FY 2022.
Its analysts commented:
Similar to previous periods, we see FY22 guidance as conservative given strong FUM growth into 4Q22, off the back of development completions and rising asset values (as GMGâs book cap rates are softer than market).
Moreover, despite fears, we see the growth outlook as being robust for FY23 as well given solid demand for industrial (which is driving market rental growth above longer-term averages) and ongoing investment demand, which should support asset value and AUM growth. We re-iterate Buy.
The post Broker names 2 of the best ASX 200 shares to buy now appeared first on The Motley Fool Australia.
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now
See The 5 Stocks
*Returns as of January 12th 2022
setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
2 ASX shares rated as strong buys by several brokers
CSL share price ‘will be significantly bigger from this point’: fundie
Top brokers name 3 ASX shares to buy next week
Why I would invest $10,000 in these 3 ASX shares
Brokers name 3 ASX shares to buy today
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.